NEWS AND EVENTS
Blog
TAmDeM #1 - Target validation and choice of indications
The Rare Diseases Foundation, with the participation and support of Sanofi Genzyme, invites you to follow the TAmDeM podcast "Training of...
PODCAST TAMDEM with Sanofi Genzyme
PODCAST TAMDEM : Training of Academics on Drug Development A podcast presented by the Rare Diseases Foundation with the...
Recruitment - Communication and fundraising manager (Alternance)
The Foundation For Rare Diseases is recruiting a communication and fundraising officer on a sandwich course! The position is available immediately. More...
EJP RD ERN Workshop
In the context of EJP RD's ERN Workshops, an in-person workshop titled "Trans-ERN Working Group for Spina Bifida (Spinal Dysraphism): Workshop for...
Happy New Year 2022
Prof. Daniel Scherman, elected to the PNA
Daniel Scherman, director of the Rare Diseases Foundation, has been elected to the National Academy of Pharmacy for his work on Rare Diseases. He is...
Discover the team of Pr Canaud / RHU-COSY
The Foundation is a partner in the RHU-COSY (Cure Overgrowth Syndromes), a 5-year project financed by the French National Research Agency as part of the...
Eurordis Open Academy: check out the new website and the new training courses
Through its Open Academy, EURORDIS aims to educate patients and patient representatives by providing them with the knowledge necessary to...
AAP of the AFM-Telethon and the FMR
On Friday, October 15, during the RARE 2021 Congress, Laurence Tiennot-Herment, President of AFM-Telethon, announced the launch of a call for...
Joint PAA with HPN-AM France
The Foundation and HPN-AM France support research projects in Health or Human and Social Sciences on paroxysmal hemoglobinuria...
Joint PAA of the Foundation and HPN-AM France
The Foundation and HPN-AM France support research projects in Health or Human and Social Sciences on paroxysmal hemoglobinuria...
Webinar Information
Following the successful implementation of three Joint Transnational Calls since 2019, EJP RD is glad to announce the upcoming launch on December...